← boothcheck

Is CNO overvalued?

boothcheck doesn't label CNO overvalued or undervalued, and it doesn't publish a fair value. It shows what the price assumes instead. At today's price, CNO is priced for growth of +16.4%. The price is justified by relative-multiple and growth-DCF; asset-based land below the price. The more the price assumes beyond what CNO Financial Group, Inc. has actually delivered, the more has to go right to justify it. Whether that bar is too high is your call, and the full bull and bear cases are in the report.

Derived from CNO Financial Group, Inc.'s SEC EDGAR filings via a reverse-DCF inversion. Last analyzed June 27, 2026.

Implied growth+16.4%
For about
Margin needed
Margin today
Price vs asset value1.84x
Price vs earnings power1.30x
Price vs peer multiples0.60x
Price vs forward growth1.01x
Read the full CNO report →
Get boothcheck's read on what CNO's price is betting on, in your inbox when it moves. No hype, no spam.
Free. Informational only, not investment advice. Unsubscribe anytime.

For informational and research purposes only. Not investment advice. Not a recommendation to buy, sell, or hold any security. boothcheck is not a registered investment adviser. Past performance does not guarantee future results.